Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
55000,,5118067,CHEMBL1637285,Antimicrobial activity against Acinetobacter sp. assessed as percent susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1629692,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1315378,=,1,0,=,Activity,%,47.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,Activity,%,UO_0000187,47.0
55001,,5140702,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55002,,5140716,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55003,,5140730,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55004,,5140746,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55005,,5140761,CHEMBL1666068,Antimicrobial activity against Streptococcus pneumoniae 1 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
55006,,5140776,CHEMBL1666069,Antimicrobial activity against Streptococcus pneumoniae 2 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55007,,5140791,CHEMBL1666070,Antimicrobial activity against Streptococcus pneumoniae 3 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55008,,5140806,CHEMBL1666071,Antimicrobial activity against Streptococcus pneumoniae 4 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
55009,,5140821,CHEMBL1666072,Antimicrobial activity against Streptococcus pneumoniae 5 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55010,,5140836,CHEMBL1666073,Antimicrobial activity against Streptococcus pneumoniae 6 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55011,,5140851,CHEMBL1666074,Antimicrobial activity against Streptococcus pneumoniae 7 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55012,,5140866,CHEMBL1666075,Antimicrobial activity against Streptococcus pneumoniae 8 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55013,,5140881,CHEMBL1666076,Antimicrobial activity against Streptococcus pneumoniae 9 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
55014,,5140896,CHEMBL1666077,Antimicrobial activity against Streptococcus pneumoniae 10 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55015,,5140911,CHEMBL1666078,Antimicrobial activity against Streptococcus pneumoniae 11 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55016,,5141981,CHEMBL1666079,Antimicrobial activity against Streptococcus pneumoniae 12 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55017,,5141997,CHEMBL1666080,Antimicrobial activity against Streptococcus pneumoniae isolate 24 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55018,,5142012,CHEMBL1666081,Antimicrobial activity against Streptococcus pneumoniae isolate 33 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55019,,5142027,CHEMBL1666082,Antimicrobial activity against Streptococcus pneumoniae isolate 37 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55020,,5142042,CHEMBL1666083,Antimicrobial activity against Streptococcus pneumoniae isolate 1055 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
55021,,5142060,CHEMBL1666229,Antimicrobial activity against Streptococcus pneumoniae isolate 1394 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55022,,5142075,CHEMBL1666230,Antimicrobial activity against Streptococcus pneumoniae isolate 1397 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55023,,5142090,CHEMBL1666231,Antimicrobial activity against Streptococcus pneumoniae isolate 1424 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55024,,5142105,CHEMBL1666232,Antimicrobial activity against Streptococcus pneumoniae isolate 1564 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55025,,5142120,CHEMBL1666233,Antimicrobial activity against Streptococcus pneumoniae isolate 2617 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55026,,5142135,CHEMBL1666234,Antimicrobial activity against Streptococcus pneumoniae isolate 2686 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55027,,5142150,CHEMBL1666235,Antimicrobial activity against Streptococcus pneumoniae isolate 2688 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55028,,5142165,CHEMBL1666236,Antimicrobial activity against Streptococcus pneumoniae isolate 2874 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55029,,5142180,CHEMBL1666237,Antimicrobial activity against Streptococcus pneumoniae isolate 2880 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55030,,5142195,CHEMBL1666238,Antimicrobial activity against Streptococcus pneumoniae isolate 3260 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55031,,5142210,CHEMBL1666240,Antimicrobial activity against Streptococcus pneumoniae isolate 3275 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55032,,5142225,CHEMBL1666241,Antimicrobial activity against Streptococcus pneumoniae isolate 3282 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55033,,5142240,CHEMBL1666242,Antimicrobial activity against Streptococcus pneumoniae isolate 3346 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55034,,5142255,CHEMBL1666243,Antimicrobial activity against Streptococcus pneumoniae isolate 3374 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55035,,5142270,CHEMBL1666244,Antimicrobial activity against Streptococcus pneumoniae isolate 3412 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55036,,5142285,CHEMBL1666245,Antimicrobial activity against Streptococcus pneumoniae isolate 3455 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
55037,,5142300,CHEMBL1666246,Antimicrobial activity against Streptococcus pneumoniae isolate 3458 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
55038,,5142315,CHEMBL1666247,Antimicrobial activity against Streptococcus pneumoniae isolate 3481 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55039,,5143383,CHEMBL1666248,Antimicrobial activity against Streptococcus pneumoniae isolate 3587 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55040,,5143398,CHEMBL1666249,Antimicrobial activity against Streptococcus pneumoniae isolate 3681 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55041,,5143413,CHEMBL1666250,Antimicrobial activity against Streptococcus pneumoniae isolate 3791 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55042,,5143428,CHEMBL1666251,Antimicrobial activity against Streptococcus pneumoniae isolate 4747 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55043,,5143443,CHEMBL1666252,Antimicrobial activity against Streptococcus pneumoniae isolate 4755 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55044,,5143471,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
55045,,5143485,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
55046,,5143499,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,1.0
55047,,5143513,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
55048,,5143527,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
55049,,5143541,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
55050,,5143560,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
55051,,5143574,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
55052,,5143618,CHEMBL1666084,Antimicrobial activity against Streptococcus pneumoniae isolate 1146 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
55053,,5143619,CHEMBL1666227,Antimicrobial activity against Streptococcus pneumoniae isolate 1147 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
55054,,5143620,CHEMBL1666228,Antimicrobial activity against Streptococcus pneumoniae isolate 1384 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55055,,5143621,CHEMBL1666239,Antimicrobial activity against Streptococcus pneumoniae isolate 3263 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326385,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55056,Not Active,5146221,CHEMBL1666707,Bactericidal activity against Klebsiella pneumoniae isolate 5427 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,INH,,UO_0000187,
55057,Not Active,5146228,CHEMBL1666708,Bactericidal activity against Klebsiella pneumoniae isolate 5436 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,INH,,UO_0000187,
55058,Not Active,5146235,CHEMBL1666709,Bactericidal activity against Escherichia coli isolate 5401 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,,UO_0000187,
55059,Not Active,5146242,CHEMBL1666710,Bactericidal activity against Escherichia coli isolate 5411 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,,UO_0000187,
55060,,5147672,CHEMBL1666896,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA Asn87 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,4.0
55061,,5147673,CHEMBL1666897,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA Asp91 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,2.0
55062,,5147674,CHEMBL1666898,Antibacterial activity against Helicobacter pylori clinical isolates harboring mutation in gyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,0.12
55063,,5147675,CHEMBL1666899,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,0.12
55064,,5147688,CHEMBL1666896,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA Asn87 mutant gene by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC50,ug ml-1,UO_0000274,8.0
55065,,5147689,CHEMBL1666897,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA Asp91 mutant gene by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC50,ug ml-1,UO_0000274,4.0
55066,,5147690,CHEMBL1666899,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA gene by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC50,ug ml-1,UO_0000274,0.25
55067,,5147691,CHEMBL1666896,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA Asn87 mutant gene by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC90,ug ml-1,UO_0000274,16.0
55068,,5147692,CHEMBL1666897,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA Asp91 mutant gene by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC90,ug ml-1,UO_0000274,8.0
55069,,5147693,CHEMBL1666899,Antibacterial activity against Helicobacter pylori clinical isolates harboring gyrA gene by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649495,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326766,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC90,ug ml-1,UO_0000274,0.25
55070,,5150451,CHEMBL1665767,Antimicrobial activity against Clostridium difficile C253E selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55071,,5150452,CHEMBL1665768,Antimicrobial activity against Clostridium difficile C253F selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55072,,5150453,CHEMBL1665772,Antimicrobial activity against Clostridium difficile CD5A harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55073,,5150454,CHEMBL1665773,Antimicrobial activity against Clostridium difficile CD5B harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55074,,5150455,CHEMBL1665774,Antimicrobial activity against Clostridium difficile CD5C harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55075,,5150456,CHEMBL1665778,Antimicrobial activity against Clostridium difficile CD5D harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55076,,5150457,CHEMBL1665779,Antimicrobial activity against Clostridium difficile CD5E harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55077,,5150458,CHEMBL1665780,Antimicrobial activity against Clostridium difficile CD5F harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55078,,5150459,CHEMBL1666642,Antimicrobial activity against Clostridium difficile A422A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55079,,5150460,CHEMBL1666643,Antimicrobial activity against Clostridium difficile A422B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55080,,5150461,CHEMBL1666644,Antimicrobial activity against Clostridium difficile A422C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55081,,5150462,CHEMBL1666648,Antimicrobial activity against Clostridium difficile A422D harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55082,,5150463,CHEMBL1666649,Antimicrobial activity against Clostridium difficile A422E harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55083,,5150464,CHEMBL1666650,Antimicrobial activity against Clostridium difficile A422F harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55084,,5150465,CHEMBL1666654,Antimicrobial activity against Clostridium difficile A422G harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55085,,5150466,CHEMBL1666655,Antimicrobial activity against Clostridium difficile A422H harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55086,,5150467,CHEMBL1666656,Antimicrobial activity against Clostridium difficile A422I harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55087,,5150468,CHEMBL1666660,Antimicrobial activity against Clostridium difficile 630A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55088,,5150469,CHEMBL1666661,Antimicrobial activity against Clostridium difficile 630B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55089,,5150470,CHEMBL1666662,Antimicrobial activity against Clostridium difficile 630C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55090,,5150471,CHEMBL1666666,Antimicrobial activity against Clostridium difficile 630D harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
55091,,5150472,CHEMBL1666667,Antimicrobial activity against Clostridium difficile 630E harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
55092,,5150473,CHEMBL1666668,Antimicrobial activity against Clostridium difficile 630F harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
55093,,5150474,CHEMBL1666672,Antimicrobial activity against Clostridium difficile BI2A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55094,,5150475,CHEMBL1666673,Antimicrobial activity against Clostridium difficile BI2B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55095,,5150476,CHEMBL1666674,Antimicrobial activity against Clostridium difficile BI2C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55096,,5150477,CHEMBL1666678,Antimicrobial activity against Clostridium difficile BI2D harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
55097,,5150478,CHEMBL1666679,Antimicrobial activity against Clostridium difficile BI2E harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
55098,,5150479,CHEMBL1666680,Antimicrobial activity against Clostridium difficile BI2F harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
55099,,5150571,CHEMBL1664909,Antimicrobial activity against Enterobacter cloacae clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,0.0
55100,,5150574,CHEMBL1664908,Antimicrobial activity against Enterobacter cloacae clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.25
55101,,5150577,CHEMBL1664907,Antimicrobial activity against Klebsiella oxytoca clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,71.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,71.0
55102,,5150580,CHEMBL1664906,Antimicrobial activity against Klebsiella oxytoca clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,0.0
55103,,5150583,CHEMBL1664905,Antimicrobial activity against Klebsiella oxytoca clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.25
55104,,5150586,CHEMBL1664904,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,87.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,87.0
55105,,5150589,CHEMBL1664903,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,13.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,13.0
55106,,5150592,CHEMBL1664902,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
55107,,5150595,CHEMBL1664901,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,100.0
55108,,5150598,CHEMBL1664900,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,0.0
55109,,5150601,CHEMBL1664899,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
55110,,5150604,CHEMBL1664898,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
55111,,5150607,CHEMBL1667541,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
55112,,5150610,CHEMBL1667540,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55113,,5150613,CHEMBL1667539,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
55114,,5150616,CHEMBL1667538,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,0.0
55115,,5150619,CHEMBL1667537,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55116,,5150622,CHEMBL1667536,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,79.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,79.0
55117,,5150625,CHEMBL1667535,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,4.0
55118,,5150628,CHEMBL1667534,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,4.0
55119,,5150631,CHEMBL1667534,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,1.0
55120,,5150634,CHEMBL1667534,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55121,,5150637,CHEMBL1667533,Antimicrobial activity against Klebsiella oxytoca isolate M2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,4.0
55122,,5150640,CHEMBL1667532,Antimicrobial activity against Klebsiella pneumoniae isolate V2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
55123,,5150643,CHEMBL1667531,Antimicrobial activity against Klebsiella pneumoniae isolate C2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
55124,,5150646,CHEMBL1667530,Antimicrobial activity against Klebsiella pneumoniae isolate M2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
55125,,5150649,CHEMBL1666839,Antimicrobial activity against Klebsiella pneumoniae isolate Y2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
55126,,5150652,CHEMBL1666838,Antimicrobial activity against Escherichia coli isolate M3 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
55127,,5150655,CHEMBL1666837,Antimicrobial activity against Escherichia coli isolate M2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55128,,5150658,CHEMBL1666836,Antimicrobial activity against Escherichia coli isolate Y3 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55129,,5150661,CHEMBL1666824,Antimicrobial activity against Escherichia coli isolate Y2 harboring qnrS1 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55130,,5150664,CHEMBL1666825,Antimicrobial activity against Citrobacter freundii isolate V1 harboring qnrB10 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.5
55131,,5150667,CHEMBL1666826,Antimicrobial activity against Klebsiella oxytoca isolate M1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.5
55132,,5150670,CHEMBL1666827,Antimicrobial activity against Enterobacter cloacae isolate V1 harboring qnrB2 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,2.0
55133,,5150673,CHEMBL1666828,Antimicrobial activity against Escherichia hermannii isolate C1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
55134,,5150676,CHEMBL1666829,Antimicrobial activity against Klebsiella pneumoniae isolate V1 harboring qnrB2 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
55135,,5150679,CHEMBL1666830,Antimicrobial activity against Klebsiella pneumoniae isolate M1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
55136,,5150682,CHEMBL1666831,Antimicrobial activity against Klebsiella pneumoniae isolate Y1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
55137,,5150685,CHEMBL1666832,Antimicrobial activity against Escherichia coli isolate V1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
55138,,5150688,CHEMBL1666834,Antimicrobial activity against Escherichia coli isolate C1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
55139,,5150691,CHEMBL1666833,Antimicrobial activity against Escherichia coli isolate M1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55140,,5150694,CHEMBL1666835,Antimicrobial activity against Escherichia coli isolate Y1 harboring qnrB19 gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
55141,,5150698,CHEMBL1664910,Antimicrobial activity against Enterobacter cloacae clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,71.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,71.0
55142,,5150701,CHEMBL1664911,Antimicrobial activity against Escherichia hermannii clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
55143,,5150704,CHEMBL1664912,Antimicrobial activity against Escherichia hermannii clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
55144,,5150707,CHEMBL1664913,Antimicrobial activity against Escherichia hermannii clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,71.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,71.0
55145,,5150710,CHEMBL1664914,Antimicrobial activity against Citrobacter freundii clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.25
55146,,5150713,CHEMBL1664915,Antimicrobial activity against Citrobacter freundii clinical isolate assessed as resistant isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,0.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,0.0
55147,,5150716,CHEMBL1664916,Antimicrobial activity against Citrobacter freundii clinical isolate assessed as susceptible isolate,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649485,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326715,=,1,0,=,Activity,%,71.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,71.0
55148,,5152104,CHEMBL1653455,"AUC in epithelial lining fluid of Swiss-Webster mouse infected with Pseudomonas aeruginosa at 200 mg/kg, ip administered as single dose",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649474,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1326522,=,1,1,=,AUC,ng.hr.mL-1,49800.0,CHEMBL612558,,ADMET,,,AUC,mg.hr/L,,49.8
55149,,5152105,CHEMBL1653328,"AUC in plasma of Swiss-Webster mouse infected with Pseudomonas aeruginosa at 200 mg/kg, ip administered as single dose",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649474,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1326522,=,1,1,=,AUC,ng.hr.mL-1,64000.0,CHEMBL612558,,ADMET,,,AUC,mg.hr/L,,64.0
55150,,5152106,CHEMBL1653327,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649474,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326522,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.5
55151,,5152107,CHEMBL1653456,"Drug uptake in epithelial lining fluid of Swiss-Webster mouse infected with Pseudomonas aeruginosa at 200 mg/kg, ip administered as single dose",A,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649474,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326522,=,1,0,=,Drug uptake,%,77.7,CHEMBL612558,,ADMET,,,Drug uptake,%,UO_0000187,77.7
55152,,5152112,CHEMBL1653461,"Antimicrobial activity against Pseudomonas aeruginosa infected in Swiss-Webster mouse at 200 mg/kg, ip administered as single dose",F,BAO_0000188,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649474,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326522,=,1,1,=,EC50,ug.mL-1,3.15,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,EC50,mg/L,UO_0000274,3.15
55153,,5152929,CHEMBL1662381,Antimicrobial activity against Proteus mirabilis 06-489 isolated from infected human urinary tract by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.5
55154,,5152930,CHEMBL1662383,Antimicrobial activity against Escherichia coli J53 transconjugated with Proteus mirabilis pHS10 carrying qnrC gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
55155,,5152931,CHEMBL1662385,Antimicrobial activity against Escherichia coli J53 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
55156,,5152952,CHEMBL1662386,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
55157,,5152953,CHEMBL1662387,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATG to ACG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
55158,,5152954,CHEMBL1662388,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to ATG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
55159,,5152955,CHEMBL1662389,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TCG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
55160,,5152956,CHEMBL1662390,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TTA substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
55161,,5152957,CHEMBL1662391,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to ATG substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
55162,,5152958,CHEMBL1662392,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to TTA substituted qnrC gene by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
55163,,5152959,CHEMBL1662393,Antimicrobial activity against Escherichia coli ATCC 25922 by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
55164,,5153268,CHEMBL1661215,Antimicrobial activity against Mycoplasma pneumoniae isolated from human by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.125
55165,,5153315,CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326464,>=,1,1,>=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
55166,,5153329,CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326464,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,2.0
55167,,5153343,CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326464,>=,1,1,>=,MIC90,ug.mL-1,64.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,64.0
55168,,5153359,CHEMBL1666521,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
55169,,5153366,CHEMBL1666522,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
55170,,5153373,CHEMBL1666523,Antimicrobial activity against AmpC-depressed Enterobacter cloacae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
55171,,5153380,CHEMBL1666524,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
55172,,5153391,CHEMBL1666521,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.06
55173,,5153398,CHEMBL1666522,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,>,1,0,>,MBC,ug ml-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MBC,ug ml-1,UO_0000274,0.25
55174,,5153405,CHEMBL1666523,Antimicrobial activity against AmpC-depressed Enterobacter cloacae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MBC,ug ml-1,UO_0000274,0.03
55175,,5153412,CHEMBL1666524,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.5
55176,,5153423,CHEMBL1666529,Antimicrobial activity against Escherichia coli isolate 5401 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
55177,,5153430,CHEMBL1666530,Antimicrobial activity against Escherichia coli isolate 5411 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
55178,,5153439,CHEMBL1666685,Antimicrobial activity against Klebsiella pneumoniae isolate 5427 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
55179,,5153446,CHEMBL1666686,Antimicrobial activity against Klebsiella pneumoniae isolate 5436 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
55180,,5153455,CHEMBL1666689,Antimicrobial activity against Enterobacter cloacae isolate 4073 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
55181,,5153462,CHEMBL1666690,Antimicrobial activity against Enterobacter cloacae isolate 5420 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
55182,,5153471,CHEMBL1666693,Antimicrobial activity against Pseudomonas aeruginosa isolate 796 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
55183,,5153478,CHEMBL1666694,Antimicrobial activity against Pseudomonas aeruginosa isolate 956 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
55184,,5153485,CHEMBL1666695,Antimicrobial activity against Pseudomonas aeruginosa isolate 1019 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
55185,,5153492,CHEMBL1666696,Antimicrobial activity against Pseudomonas aeruginosa isolate 1037 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
55186,,5153503,CHEMBL1666529,Antimicrobial activity against Escherichia coli isolate 5401 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,32.0
55187,,5153510,CHEMBL1666530,Antimicrobial activity against Escherichia coli isolate 5411 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,16.0
55188,,5153519,CHEMBL1666685,Antimicrobial activity against Klebsiella pneumoniae isolate 5427 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MBC,ug ml-1,UO_0000274,2.0
55189,,5153526,CHEMBL1666686,Antimicrobial activity against Klebsiella pneumoniae isolate 5436 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MBC,ug ml-1,UO_0000274,4.0
55190,,5153535,CHEMBL1666689,Antimicrobial activity against Enterobacter cloacae isolate 4073 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MBC,ug ml-1,UO_0000274,0.06
55191,,5153542,CHEMBL1666690,Antimicrobial activity against Enterobacter cloacae isolate 5420 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MBC,ug ml-1,UO_0000274,0.06
55192,,5153551,CHEMBL1666693,Antimicrobial activity against Pseudomonas aeruginosa isolate 796 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,2.0
55193,,5153558,CHEMBL1666694,Antimicrobial activity against Pseudomonas aeruginosa isolate 956 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,1.0
55194,,5153565,CHEMBL1666695,Antimicrobial activity against Pseudomonas aeruginosa isolate 1019 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,1.0
55195,,5153572,CHEMBL1666696,Antimicrobial activity against Pseudomonas aeruginosa isolate 1037 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.5
55196,Not Active,5153583,CHEMBL1666701,Bactericidal activity against Pseudomonas aeruginosa isolate 796 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
55197,Not Active,5153590,CHEMBL1666702,Bactericidal activity against Pseudomonas aeruginosa isolate 956 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
55198,Not Active,5153597,CHEMBL1666703,Bactericidal activity against Pseudomonas aeruginosa isolate 1019 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
55199,Not Active,5153604,CHEMBL1666704,Bactericidal activity against Pseudomonas aeruginosa isolate 1037 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
55200,Not Active,5153611,CHEMBL1666705,Bactericidal activity against Enterobacter cloacae isolate 4073 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,INH,,UO_0000187,
55201,Not Active,5153618,CHEMBL1666706,Bactericidal activity against Enterobacter cloacae isolate 5420 at 1/4 times MIC after 24 hrs by time kill analysis,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,Inhibition,%,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,INH,,UO_0000187,
55202,,5154314,CHEMBL1662077,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 500 mg, po BID for 10 days by 13C-urea breath test",F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1325736,=,1,0,=,Activity,%,66.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,Activity,%,UO_0000187,66.0
55203,,5154334,CHEMBL1662077,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 500 mg, po BID for 10 days by 13C-urea breath test",F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325736,=,1,0,=,Activity,mg,500.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,Activity,mg,UO_0000022,500.0
55204,,5154347,CHEMBL1661216,Antimicrobial activity against Mycoplasma genitalium isolated from human by two fold serial dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
55205,,5154353,CHEMBL1661219,Antimicrobial activity against Ureaplasma parvum isolated from human by two fold serial dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
55206,,5154359,CHEMBL1661220,Antimicrobial activity against Ureaplasma urealyticum isolated from human by two fold serial dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.5
55207,,5154365,CHEMBL1661215,Antimicrobial activity against Mycoplasma pneumoniae isolated from human by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.5
55208,,5154371,CHEMBL1661219,Antimicrobial activity against Ureaplasma parvum isolated from human by two fold serial dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
55209,,5154377,CHEMBL1661220,Antimicrobial activity against Ureaplasma urealyticum isolated from human by two fold serial dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
55210,,5154383,CHEMBL1661215,Antimicrobial activity against Mycoplasma pneumoniae isolated from human by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,0.5
55211,,5154389,CHEMBL1661219,Antimicrobial activity against Ureaplasma parvum isolated from human by two fold serial dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,2.0
55212,,5154395,CHEMBL1661220,Antimicrobial activity against Ureaplasma urealyticum isolated from human by two fold serial dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1.0
55213,,5154402,CHEMBL1661217,Antimicrobial activity against Mycoplasma fermentans isolated from human by two fold serial dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.008
55214,,5154409,CHEMBL1661218,Antimicrobial activity against Mycoplasma hominis isolated from human by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC,ug ml-1,UO_0000274,0.125
55215,,5154416,CHEMBL1661217,Antimicrobial activity against Mycoplasma fermentans isolated from human by two fold serial dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC50,ug.mL-1,0.031,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.031
55216,,5154423,CHEMBL1661218,Antimicrobial activity against Mycoplasma hominis isolated from human by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC50,ug ml-1,UO_0000274,0.25
55217,,5154430,CHEMBL1661217,Antimicrobial activity against Mycoplasma fermentans isolated from human by two fold serial dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.125
55218,,5154437,CHEMBL1661218,Antimicrobial activity against Mycoplasma hominis isolated from human by two fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC90,ug ml-1,UO_0000274,0.5
55219,,5155449,CHEMBL1662944,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,1.0
55220,,5155450,CHEMBL1662945,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,64.0
55221,,5155451,CHEMBL1662947,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,2.0
55222,,5155452,CHEMBL1662948,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,16.0
55223,,5155453,CHEMBL1662949,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,32.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Time,hr,UO_0000032,32.0
55224,,5155454,CHEMBL1663083,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,256.0
55225,,5155455,CHEMBL1662950,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,64.0
55226,,5155456,CHEMBL1663087,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,256.0
55227,,5155457,CHEMBL1663084,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55228,,5155458,CHEMBL1663088,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,128.0
55229,,5155459,CHEMBL1663090,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,0.0
55230,,5155460,CHEMBL1663092,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,2.0
55231,,5155461,CHEMBL1663091,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55232,,5155462,CHEMBL1663093,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55233,,5155463,CHEMBL1663095,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,2.0
55234,,5155464,CHEMBL1663096,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,64.0
55235,,5155465,CHEMBL1663099,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,128.0
55236,,5155466,CHEMBL1663098,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,4.0
55237,,5155467,CHEMBL1663101,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,128.0
55238,,5155468,CHEMBL1663100,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,32.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Time,hr,UO_0000032,32.0
55239,,5155469,CHEMBL1661310,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,512.0
55240,,5155470,CHEMBL1661312,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55241,,5155471,CHEMBL1661315,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,1024.0
55242,,5155472,CHEMBL1661316,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,256.0
55243,,5155473,CHEMBL1661318,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,0.0
55244,,5155474,CHEMBL1661319,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55245,,5155475,CHEMBL1661320,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,2.0
55246,,5155476,CHEMBL1661321,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55247,,5155477,CHEMBL1661323,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,4.0
55248,,5155478,CHEMBL1661324,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,128.0
55249,,5155479,CHEMBL1661326,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,4.0
55250,,5155480,CHEMBL1661327,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,128.0
55251,,5155481,CHEMBL1661328,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Time,hr,UO_0000032,128.0
55252,,5155482,CHEMBL1661329,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,256.0
55253,,5155483,CHEMBL1661334,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,1024.0
55254,,5155484,CHEMBL1661336,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4096.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,4096.0
55255,,5155485,CHEMBL1661460,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,1024.0
55256,,5155486,CHEMBL1661339,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,128.0
55257,,5155487,CHEMBL1661462,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,0.0
55258,,5155488,CHEMBL1661463,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55259,,5155641,CHEMBL1661719,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.25
55260,,5155643,CHEMBL1661718,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,4.0
55261,,5155644,CHEMBL1661716,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,16.0
55262,,5155645,CHEMBL1661717,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,8.0
55263,,5155646,CHEMBL1661715,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
55264,,5155647,CHEMBL1661714,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,8.0
55265,,5155648,CHEMBL1661712,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.125
55266,,5155649,CHEMBL1661713,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,1.0
55267,Not Determined,5155650,CHEMBL1661711,Antimicrobial activity against Staphylococcus haemolyticus 1949819 B-M isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,,,
55268,,5155651,CHEMBL1661709,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,32.0
55269,,5155652,CHEMBL1661710,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/L,UO_0000274,32.0
55270,,5155653,CHEMBL1661708,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,32.0
55271,,5155654,CHEMBL1661707,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55272,Not Determined,5155655,CHEMBL1661706,Antimicrobial activity against Escherichia coli 2297257 B-W isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
55273,,5155656,CHEMBL1661704,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.047
55274,,5155657,CHEMBL1661705,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.047
55275,Not Determined,5155658,CHEMBL1661702,Antimicrobial activity against Escherichia coli 1821385 B-C isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
55276,Not Determined,5155659,CHEMBL1661703,Antimicrobial activity against Escherichia coli 1780063 B-A isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
55277,,5155660,CHEMBL1661700,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.03
55278,,5155661,CHEMBL1661699,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.03
55279,,5155662,CHEMBL1661701,Antimicrobial activity against Escherichia coli 1889646 B-F isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,8.0
55280,Not Determined,5155663,CHEMBL1661698,Antimicrobial activity against Escherichia coli 1889645 B-I isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
55281,,5155664,CHEMBL1661697,Antimicrobial activity against Escherichia coli 1949825 B-K isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.03
55282,Not Determined,5155665,CHEMBL1661695,Antimicrobial activity against Escherichia coli 1949826 B-L isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
55283,,5155666,CHEMBL1661696,Antimicrobial activity against Escherichia coli 2062717 B-P isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,8.0
55284,,5155667,CHEMBL1661694,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.032
55285,,5155668,CHEMBL1661691,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.25
55286,,5155669,CHEMBL1661693,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,mg/L,UO_0000274,0.19
55287,,5155670,CHEMBL1661692,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,0.06
55288,,5155671,CHEMBL1661689,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.06
55289,Not Determined,5155672,CHEMBL1661690,Antimicrobial activity against Enterococcus faecalis 2215770 B-T isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325741,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
55290,,5155673,CHEMBL1661688,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/L,UO_0000274,8.0
55291,,5155674,CHEMBL1661687,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,16.0
55292,,5155675,CHEMBL1661685,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,8.0
55293,,5155676,CHEMBL1661555,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,2.0
55294,,5155677,CHEMBL1661686,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Time,hr,UO_0000032,0.0
55295,,5155678,CHEMBL1660829,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,8.0
55296,,5155679,CHEMBL1660827,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,32.0
55297,,5155680,CHEMBL1660828,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,4.0
55298,,5155681,CHEMBL1660826,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,192.0
55299,,5155682,CHEMBL1660824,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,8.0
55300,,5155683,CHEMBL1660825,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,16.0
55301,,5155684,CHEMBL1660822,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Time,hr,UO_0000032,0.0
55302,,5155685,CHEMBL1660823,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,2.0
55303,,5155686,CHEMBL1660821,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,4.0
55304,,5155687,CHEMBL1660819,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,16.0
55305,,5155688,CHEMBL1660820,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2.0
55306,,5155689,CHEMBL1660818,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,128.0
55307,,5155690,CHEMBL1660817,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,8.0
55308,,5155691,CHEMBL1660816,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,3.0
55309,,5155692,CHEMBL1660815,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Time,hr,UO_0000032,0.0
55310,,5155693,CHEMBL1660814,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,1.0
55311,,5155694,CHEMBL1660813,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,4.0
55312,,5155695,CHEMBL1660812,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,0.5
55313,,5155696,CHEMBL1660676,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,64.0
55314,,5155697,CHEMBL1660677,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,16.0
55315,,5155698,CHEMBL1660675,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,8.0
55316,,5155699,CHEMBL1660674,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2.5
55317,,5155700,CHEMBL1660673,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Time,hr,UO_0000032,0.0
55318,,5155701,CHEMBL1660672,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,1.0
55319,,5155702,CHEMBL1660670,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,4.0
55320,,5155703,CHEMBL1660671,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,0.5
55321,,5155704,CHEMBL1660669,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,16.0
55322,,5155705,CHEMBL1660668,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,48.0
55323,,5155706,CHEMBL1660667,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,6.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,6.0
55324,,5155707,CHEMBL1660666,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,3.0
55325,,5155708,CHEMBL1660664,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,1.0
55326,,5155709,CHEMBL1660665,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Time,hr,UO_0000032,0.0
55327,,5155710,CHEMBL1660663,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,2.0
55328,,5155711,CHEMBL1660662,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,1.0
55329,,5155712,CHEMBL1660661,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,8.0
55330,,5155713,CHEMBL1660660,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,48.0
55331,,5155714,CHEMBL1660657,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2.0
55332,,5155715,CHEMBL1660659,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,4.0
55333,,5155716,CHEMBL1660658,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Time,hr,UO_0000032,0.0
55334,,5155717,CHEMBL1660656,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,0.0
55335,,5155718,CHEMBL1660655,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,2.0
55336,,5155719,CHEMBL1660654,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,0.0
55337,,5155720,CHEMBL1660653,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,6.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,6.0
55338,,5155721,CHEMBL1660652,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,40.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,40.0
55339,,5155722,CHEMBL1660649,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,1.0
55340,,5155723,CHEMBL1660650,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55341,,5155724,CHEMBL1660648,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55342,,5155725,CHEMBL1660647,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,0.0
55343,,5155726,CHEMBL1660645,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,1024.0
55344,,5155727,CHEMBL1660644,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55345,,5155728,CHEMBL1662434,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55346,,5155729,CHEMBL1662433,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55347,,5155730,CHEMBL1662427,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,1024.0
55348,,5155731,CHEMBL1662426,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,512.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Time,hr,UO_0000032,512.0
55349,,5155732,CHEMBL1662425,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,32.0
55350,,5155733,CHEMBL1662300,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,8.0
55351,,5155734,CHEMBL1662298,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,256.0
55352,,5155735,CHEMBL1662297,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,4.0
55353,,5155736,CHEMBL1662295,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55354,,5155737,CHEMBL1662294,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,1.0
55355,,5155738,CHEMBL1662293,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55356,,5155739,CHEMBL1662292,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,0.0
55357,,5155740,CHEMBL1662290,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,512.0
55358,,5155741,CHEMBL1662289,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55359,,5155742,CHEMBL1662285,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,8192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,8192.0
55360,,5155743,CHEMBL1662284,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55361,,5155744,CHEMBL1662279,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,512.0
55362,,5155745,CHEMBL1662278,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Time,hr,UO_0000032,256.0
55363,,5155746,CHEMBL1662277,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,128.0
55364,,5155747,CHEMBL1662276,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,4.0
55365,,5155748,CHEMBL1662274,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,128.0
55366,,5155749,CHEMBL1662273,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,4.0
55367,,5155750,CHEMBL1662271,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55368,,5155751,CHEMBL1662270,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,4.0
55369,,5155752,CHEMBL1662269,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,1.0
55370,,5155753,CHEMBL1662268,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,1.0
55371,,5155754,CHEMBL1662266,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,256.0
55372,,5155755,CHEMBL1662154,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55373,,5155756,CHEMBL1662151,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,2048.0
55374,,5155757,CHEMBL1661477,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,512.0
55375,,5155758,CHEMBL1661473,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,512.0
55376,,5155759,CHEMBL1661472,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Time,hr,UO_0000032,128.0
55377,,5155760,CHEMBL1661471,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,128.0
55378,,5155761,CHEMBL1661470,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Time,hr,UO_0000032,4.0
55379,,5155762,CHEMBL1661468,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,128.0
55380,,5155763,CHEMBL1661467,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,2.0
55381,,5155764,CHEMBL1661465,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,0.0
55382,,5155765,CHEMBL1661464,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,TIME,hr,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Time,hr,UO_0000032,2.0
55383,,5156464,CHEMBL1666604,Antimicrobial activity against Clostridium difficile C253 expressing tcdA and tcdB gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55384,,5156465,CHEMBL1666605,"Antimicrobial activity against Clostridium difficile CD25 expressing tcdA, tcdB gene and GyrB Ser416Ala mutant by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55385,,5156466,CHEMBL1666606,Antimicrobial activity against Clostridium difficile A422 expressing tcdA and tcdB gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55386,,5156467,CHEMBL1666607,Antimicrobial activity against Clostridium difficile 630 expressing tcdA and tcdB gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55387,,5156468,CHEMBL1667325,Antimicrobial activity against Clostridium difficile BI2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55388,,5156469,CHEMBL1667331,Antimicrobial activity against Clostridium difficile C253a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55389,,5156470,CHEMBL1667332,Antimicrobial activity against Clostridium difficile C253b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55390,,5156471,CHEMBL1667333,Antimicrobial activity against Clostridium difficile C253c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55391,,5156472,CHEMBL1667337,Antimicrobial activity against Clostridium difficile C253d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55392,,5156473,CHEMBL1667459,Antimicrobial activity against Clostridium difficile C253e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55393,,5156474,CHEMBL1667460,Antimicrobial activity against Clostridium difficile C253f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55394,,5156475,CHEMBL1667464,Antimicrobial activity against Clostridium difficile C253g harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55395,,5156476,CHEMBL1667465,Antimicrobial activity against Clostridium difficile C253h harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55396,,5156477,CHEMBL1667466,Antimicrobial activity against Clostridium difficile C253i harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55397,,5156478,CHEMBL1667470,Antimicrobial activity against Clostridium difficile CD5a harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55398,,5156479,CHEMBL1667471,Antimicrobial activity against Clostridium difficile CD5b harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55399,,5156480,CHEMBL1667472,Antimicrobial activity against Clostridium difficile CD5c harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55400,,5156481,CHEMBL1667476,Antimicrobial activity against Clostridium difficile CD5d harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55401,,5156482,CHEMBL1667477,Antimicrobial activity against Clostridium difficile CD5e harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55402,,5156483,CHEMBL1667478,Antimicrobial activity against Clostridium difficile CD5f harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55403,,5156484,CHEMBL1667482,Antimicrobial activity against Clostridium difficile CD5 1-g harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
55404,,5156485,CHEMBL1667483,Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
55405,,5156486,CHEMBL1667484,Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
55406,,5156487,CHEMBL1667488,"Antimicrobial activity against Clostridium difficile CD5 2-g harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55407,,5156488,CHEMBL1667489,"Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55408,,5156489,CHEMBL1667490,"Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55409,,5156490,CHEMBL1667494,Antimicrobial activity against Clostridium difficile A422a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55410,,5156491,CHEMBL1667495,Antimicrobial activity against Clostridium difficile A422b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55411,,5156492,CHEMBL1667496,Antimicrobial activity against Clostridium difficile A422c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55412,,5156493,CHEMBL1667627,Antimicrobial activity against Clostridium difficile A422d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55413,,5156494,CHEMBL1667628,Antimicrobial activity against Clostridium difficile A422e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55414,,5156495,CHEMBL1667629,Antimicrobial activity against Clostridium difficile A422f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55415,,5156496,CHEMBL1665591,Antimicrobial activity against Clostridium difficile A422g harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55416,,5156497,CHEMBL1665592,Antimicrobial activity against Clostridium difficile A422h harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55417,,5156498,CHEMBL1665593,Antimicrobial activity against Clostridium difficile A422i harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55418,,5156499,CHEMBL1665597,Antimicrobial activity against Clostridium difficile 630a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55419,,5156500,CHEMBL1665598,Antimicrobial activity against Clostridium difficile 630b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55420,,5156501,CHEMBL1665599,Antimicrobial activity against Clostridium difficile 630c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55421,,5156502,CHEMBL1665603,Antimicrobial activity against Clostridium difficile 630d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55422,,5156503,CHEMBL1665604,Antimicrobial activity against Clostridium difficile 630e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55423,,5156504,CHEMBL1665605,Antimicrobial activity against Clostridium difficile 630f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
55424,,5156505,CHEMBL1665609,Antimicrobial activity against Clostridium difficile 630g harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55425,,5156506,CHEMBL1665610,Antimicrobial activity against Clostridium difficile 630h harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55426,,5156507,CHEMBL1665611,Antimicrobial activity against Clostridium difficile 630i harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55427,,5156508,CHEMBL1665615,Antimicrobial activity against Clostridium difficile BI2a harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
55428,,5156509,CHEMBL1665616,Antimicrobial activity against Clostridium difficile BI2b harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
55429,,5156510,CHEMBL1665617,Antimicrobial activity against Clostridium difficile BI2c harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
55430,,5156511,CHEMBL1665621,Antimicrobial activity against Clostridium difficile BI2d harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55431,,5156512,CHEMBL1665755,Antimicrobial activity against Clostridium difficile BI2e harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55432,,5156513,CHEMBL1665756,Antimicrobial activity against Clostridium difficile BI2f harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
55433,,5156514,CHEMBL1665760,Antimicrobial activity against Clostridium difficile C253A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55434,,5156515,CHEMBL1665761,Antimicrobial activity against Clostridium difficile C253B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55435,,5156516,CHEMBL1665762,Antimicrobial activity against Clostridium difficile C253C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
55436,,5156517,CHEMBL1665766,Antimicrobial activity against Clostridium difficile C253D selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
55437,,5157370,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.015
55438,,5157380,CHEMBL1660791,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
55439,,5157390,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.25
55440,,5157400,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,0.5
55441,,5158065,CHEMBL1655751,Antimicrobial activity against Bacteroides sp. in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,=,1,0,=,FC,,1.0,CHEMBL613908,Bacteroides sp.,Bacteroides sp.,29523.0,,FC,,,1.0
55442,Not Active,5158066,CHEMBL1655752,Antimicrobial activity against Lactobacillus in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
55443,Not Active,5158067,CHEMBL1655753,Antimicrobial activity against Clostridium in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
55444,Not Active,5158068,CHEMBL1655754,Antimicrobial activity against Enterococcus in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,,1,0,,Activity,,,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,Activity,,,
55445,Active,5158074,CHEMBL1656249,Induction of cytotoxin production in Clostridium difficile PCR ribotype 027 in three-stage chemostat gut model at 63 mg/liter administered daily for 7 days measured after 2 days,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
55446,Active,5158075,CHEMBL1656250,Induction of cytotoxin production in Clostridium difficile PCR ribotype 001 in three-stage chemostat gut model at 63 mg/liter administered daily for 7 days measured after 3 days,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
55447,,5158080,CHEMBL1656245,Drug level in human feces,A,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1325345,=,1,0,=,Drug uptake,mg Kg-1,94.0,CHEMBL612558,,ADMET,,,Drug uptake,mg Kg-1,UO_0000308,94.0
55448,,5158085,CHEMBL1656241,Antimicrobial activity against Clostridium difficile PCR ribotype 027 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325345,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,256.0
55449,,5158086,CHEMBL1656242,Antimicrobial activity against Clostridium difficile PCR ribotype 001 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325345,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,256.0
55450,,5160059,CHEMBL1653134,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,16.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,16.8
55451,,5160068,CHEMBL1653137,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,5.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,5.6
55452,,5160216,CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
55453,,5160226,CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
55454,,5160236,CHEMBL1654553,Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
55455,,5160245,CHEMBL1653759,Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC,ug ml-1,UO_0000274,0.25
55456,,5161310,CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
55457,,5161319,CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
55458,,5161329,CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
55459,,5161339,CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,4.0
55460,,5161349,CHEMBL1654553,Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC90,ug ml-1,UO_0000274,1.0
55461,,5161358,CHEMBL1653759,Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC90,ug ml-1,UO_0000274,1.0
55462,,5161366,CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
55463,,5161375,CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
55464,,5161385,CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
55465,,5161395,CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
55466,,5161405,CHEMBL1654553,Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC50,ug ml-1,UO_0000274,0.5
55467,,5161414,CHEMBL1653759,Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC50,ug ml-1,UO_0000274,0.5
55468,,5161422,CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
55469,,5161431,CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
55470,,5161447,CHEMBL1653129,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,82.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,82.4
55471,,5161456,CHEMBL1653127,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,94.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,94.2
55472,,5161464,CHEMBL1653013,Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,100.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,Activity,%,UO_0000187,100.0
55473,,5161473,CHEMBL1653011,Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,0.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,Activity,%,UO_0000187,0.0
55474,,5161482,CHEMBL1653009,Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,99.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,Activity,%,UO_0000187,99.5
55475,,5161491,CHEMBL1653007,Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,Activity,%,UO_0000187,0.5
55476,,5161501,CHEMBL1653002,Antibacterial activity against Enterococcus faecalis assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,65.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,65.2
55477,,5161511,CHEMBL1652999,Antibacterial activity against Enterococcus faecalis assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,34.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,34.2
55478,,5161521,CHEMBL1653000,Antibacterial activity against Enterococcus faecium assessed as susceptible isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,14.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,14.2
55479,,5161531,CHEMBL1652997,Antibacterial activity against Enterococcus faecium assessed as resistant isolates by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,Activity,%,82.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,82.2
55480,,5162740,CHEMBL1665066,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55481,,5162741,CHEMBL1665067,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
55482,,5162742,CHEMBL1665784,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55483,,5162743,CHEMBL1665785,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55484,,5162744,CHEMBL1665786,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
55485,,5162745,CHEMBL1665787,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
55486,,5162746,CHEMBL1665788,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
55487,,5162747,CHEMBL1665789,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
55488,,5162788,CHEMBL1665931,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,2.0
55489,,5162789,CHEMBL1665932,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,2.0
55490,,5162790,CHEMBL1665933,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,16.0
55491,,5162791,CHEMBL1665934,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,16.0
55492,,5162792,CHEMBL1665935,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,32.0
55493,,5162793,CHEMBL1665936,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,32.0
55494,,5162837,CHEMBL1665937,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,Activity,ug ml-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,128.0
55495,,5162838,CHEMBL1665938,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327008,=,1,0,=,Activity,%,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,128.0
55496,,5163005,CHEMBL1665120,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327030,=,1,1,=,MIC,ug.mL-1,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.006
55497,,5163012,CHEMBL1665121,Antibacterial activity against quinolone-resistant Escherichia coli TOP10-3963 transformant harboring qnrS1 gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327030,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
55498,,5163019,CHEMBL1665119,Antibacterial activity against Escherichia coli 3963 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327030,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
55499,,5163748,CHEMBL1654045,Antibacterial activity against quinolone-susceptible Bordetella pertussis CCUG 30837 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
55500,,5163749,CHEMBL1654046,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP101 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
55501,,5163750,CHEMBL1654047,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP106 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
55502,,5163751,CHEMBL1654048,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP109 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.004
55503,,5163752,CHEMBL1654049,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP111 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
55504,,5163753,CHEMBL1654050,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP112 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
55505,,5163754,CHEMBL1654051,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP113 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
55506,,5163755,CHEMBL1654052,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP115 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.008
55507,,5163756,CHEMBL1654053,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP128 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.016
55508,,5163757,CHEMBL1654054,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP58 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.064
55509,,5163758,CHEMBL1654055,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP99 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.064
55510,,5163759,CHEMBL1654056,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP117 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.064
55511,,5163760,CHEMBL1654057,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP118 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.064
55512,,5163761,CHEMBL1654058,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP121 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.064
55513,,5163762,CHEMBL1654059,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP122 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,MIC,ug ml-1,UO_0000274,0.064
55514,,5164471,CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323848,<=,1,1,<=,MIC50,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.008
55515,,5164482,CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323848,<=,1,1,<=,MIC90,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.008
55516,,5164493,CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323848,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.008
55517,,5164501,CHEMBL1658622,Antimicrobial activity against Neisseria meningitidis assessed as susceptible isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1323848,=,1,0,=,Activity,%,97.1,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,97.1
55518,,5164502,CHEMBL1658623,Antimicrobial activity against Neisseria meningitidis assessed as resistant isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1323848,=,1,0,=,Activity,%,1.9,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,1.9
55519,,5165433,CHEMBL1657977,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
55520,,5165443,CHEMBL1657977,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
55521,,5166197,CHEMBL1666959,Antimicrobial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,77.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,77.0
55522,,5166198,CHEMBL1666956,Antimicrobial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,83.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,%,UO_0000187,83.0
55523,,5166199,CHEMBL1666963,Antimicrobial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,79.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,79.0
55524,,5166200,CHEMBL1666966,Antimicrobial activity against extended spectrum beta-lactamase-expressing Escherichia coli assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,21.0
55525,,5166201,CHEMBL1666969,Antimicrobial activity against extended spectrum beta-lactamase-deficient Escherichia coli assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,72.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,72.0
55526,,5166202,CHEMBL1666972,Antimicrobial activity against extended spectrum beta-lactamase-expressing Klebsiella oxytoca assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,41.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,41.0
55527,,5166203,CHEMBL1666975,Antimicrobial activity against extended spectrum beta-lactamase-deficient Klebsiella oxytoca assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,97.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,97.0
55528,,5166204,CHEMBL1666965,Antimicrobial activity against extended spectrum beta-lactamase-expressing Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,43.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,43.0
55529,,5166205,CHEMBL1666980,Antimicrobial activity against extended spectrum beta-lactamase-deficient Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,94.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,94.0
55530,,5166206,CHEMBL1666983,Antimicrobial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,84.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,84.0
55531,,5166207,CHEMBL1666986,Antimicrobial activity against Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,Activity,%,73.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,73.0
55532,,5166287,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.25
55533,,5166295,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.12
55534,,5166304,CHEMBL1667173,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
55535,,5166311,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
55536,,5166319,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,ug ml-1,UO_0000274,1.0
55537,,5166326,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,ug ml-1,UO_0000274,0.5
55538,Not Active,5166333,CHEMBL1667172,Antibacterial activity against Listeria monocytogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
55539,,5166340,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,0.25
55540,,5166347,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,128.0
55541,,5166354,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,32.0
55542,,5166361,CHEMBL1667171,Antibacterial activity against vancomycin- resistant Enterococcus faecium assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,30.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,30.9
55543,,5166368,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
55544,,5166375,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,64.0
55545,,5166382,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
55546,,5166389,CHEMBL1667170,Antibacterial activity against vancomycin- resistant Enterococcus faecalis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,58.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,58.5
55547,,5166396,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.12
55548,,5166404,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
55549,,5166411,CHEMBL1667174,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
55550,,5166420,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
55551,,5166428,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
55552,,5166436,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
55553,,5166443,CHEMBL1667175,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
55554,,5166452,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.12
55555,Not Active,5166460,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,MIC90,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,,,
55556,,5166468,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
55557,,5166476,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.06
55558,,5166484,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.06
55559,,5166492,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC,ug ml-1,UO_0000274,0.06
55560,,5166500,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.06
55561,,5166508,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC,ug ml-1,UO_0000274,0.06
55562,,5166518,CHEMBL1657977,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,128.0
55563,,5166528,CHEMBL1657978,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
55564,,5166538,CHEMBL1657978,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.125
55565,,5166548,CHEMBL1657978,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
55566,,5166558,CHEMBL1657998,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,18.0
55567,,5166566,CHEMBL1657997,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,81.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,81.0
55568,,5166574,CHEMBL1657996,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,82.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,82.0
55569,,5166581,CHEMBL1657995,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,15.0
55570,,5166588,CHEMBL1657994,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
55571,,5166598,CHEMBL1657994,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,16.0
55572,,5166608,CHEMBL1657994,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,512.0
55573,,5166618,CHEMBL1657992,Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
55574,,5166628,CHEMBL1657992,Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,1.0
55575,,5166638,CHEMBL1657992,Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,8.0
55576,,5166648,CHEMBL1657993,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.25
55577,,5166658,CHEMBL1657993,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,0.25
55578,,5166668,CHEMBL1657993,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,4.0
55579,,5166678,CHEMBL1657991,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,26.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,26.0
55580,,5166686,CHEMBL1657990,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,59.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,59.0
55581,,5166693,CHEMBL1657989,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MBC,ug ml-1,UO_0000274,0.5
55582,,5166703,CHEMBL1657989,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MBC50,ug ml-1,UO_0000274,4.0
55583,,5166713,CHEMBL1657989,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,16.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MBC90,ug ml-1,UO_0000274,16.0
55584,,5166723,CHEMBL1657988,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
55585,,5166733,CHEMBL1657988,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.25
55586,,5166743,CHEMBL1657988,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,4.0
55587,,5166753,CHEMBL1657987,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,26.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,26.0
55588,,5166761,CHEMBL1657986,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,59.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,59.0
55589,,5166768,CHEMBL1657985,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.5
55590,,5166778,CHEMBL1657985,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC50,ug ml-1,UO_0000274,4.0
55591,,5166788,CHEMBL1657985,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC90,ug ml-1,UO_0000274,16.0
55592,,5166798,CHEMBL1657984,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.25
55593,,5166808,CHEMBL1657984,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,0.25
55594,,5166818,CHEMBL1657984,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,4.0
55595,,5166828,CHEMBL1657983,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,26.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,26.0
55596,,5166836,CHEMBL1657982,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,59.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,59.0
55597,,5166843,CHEMBL1657981,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MBC,ug ml-1,UO_0000274,0.5
55598,,5166853,CHEMBL1657981,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MBC50,ug ml-1,UO_0000274,4.0
55599,,5167562,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,8.0
55600,,5167570,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,4.0
55601,,5167578,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,8.0
55602,,5167586,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.25
55603,,5167594,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.25
55604,,5167602,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC50,ug ml-1,UO_0000274,0.12
55605,Not Active,5167610,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,MIC90,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,,,
55606,,5167618,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,8.0
55607,,5167626,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,8.0
55608,,5167634,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,8.0
55609,,5167642,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,0.5
55610,,5167650,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC90,ug ml-1,UO_0000274,8.0
55611,,5167657,CHEMBL1667176,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
55612,,5167665,CHEMBL1667177,Antibacterial activity against Staphylococcus haemolyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,37.6,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,37.6
55613,,5167673,CHEMBL1667178,Antibacterial activity against Staphylococcus hominis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,30.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,30.0
55614,,5167681,CHEMBL1667179,Antibacterial activity against Staphylococcus lugdunensis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,66.7,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,66.7
55615,,5167689,CHEMBL1667180,Antibacterial activity against Staphylococcus saprophyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,Activity,%,UO_0000187,100.0
55616,,5167697,CHEMBL1667181,Antibacterial activity against Staphylococcus warneri assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,74.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,Activity,%,UO_0000187,74.0
55617,,5167705,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
55618,,5167713,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
55619,,5167721,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC,ug ml-1,UO_0000274,0.12
55620,,5167729,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
55621,,5167737,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.5
55622,,5167745,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
55623,,5167753,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,0.5
55624,,5167761,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.5
55625,,5167769,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,0.5
55626,,5167777,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
55627,,5167785,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,0.5
55628,,5167793,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
55629,Not Active,5167801,CHEMBL1667182,Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,,,
55630,Not Active,5167809,CHEMBL1667183,Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
55631,Not Active,5167817,CHEMBL1667184,Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,Activity,,,
55632,Not Active,5167825,CHEMBL1667185,Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
55633,,5167833,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
55634,,5167840,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
55635,,5167847,CHEMBL1667186,Antibacterial activity against levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
55636,,5167854,CHEMBL1667187,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
55637,,5167861,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
55638,,5167868,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,16.0
55639,,5167875,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
55640,,5167882,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,16.0
55641,,5167890,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
55642,,5167898,CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
55643,,5167908,CHEMBL1657981,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,16.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MBC90,ug ml-1,UO_0000274,16.0
55644,,5167918,CHEMBL1657980,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC,ug ml-1,UO_0000274,0.25
55645,,5167928,CHEMBL1657980,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC50,ug ml-1,UO_0000274,0.25
55646,,5167938,CHEMBL1657980,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC90,ug ml-1,UO_0000274,4.0
55647,,5167947,CHEMBL1657979,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,Activity,%,UO_0000187,15.0
55648,,5167953,CHEMBL1658118,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,59.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,Activity,%,UO_0000187,59.0
55649,,5167960,CHEMBL1658119,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MBC,ug ml-1,UO_0000274,0.5
55650,,5167970,CHEMBL1658119,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MBC50,ug ml-1,UO_0000274,4.0
55651,,5167980,CHEMBL1658119,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,16.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MBC90,ug ml-1,UO_0000274,16.0
55652,,5167990,CHEMBL1658120,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC,ug ml-1,UO_0000274,0.25
55653,,5168000,CHEMBL1658120,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC50,ug ml-1,UO_0000274,0.25
55654,,5168010,CHEMBL1658120,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC90,ug ml-1,UO_0000274,4.0
55655,,5168019,CHEMBL1658121,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,Activity,%,UO_0000187,15.0
55656,,5168025,CHEMBL1658122,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,59.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,Activity,%,UO_0000187,59.0
55657,,5168032,CHEMBL1658123,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MBC,ug ml-1,UO_0000274,0.5
55658,,5168042,CHEMBL1658123,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MBC50,ug ml-1,UO_0000274,4.0
55659,,5168052,CHEMBL1658123,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,16.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MBC90,ug ml-1,UO_0000274,16.0
55660,,5168062,CHEMBL1658124,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.25
55661,,5168072,CHEMBL1658124,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,0.25
55662,,5168082,CHEMBL1658124,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,0.5
55663,,5168092,CHEMBL1658125,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,96.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,96.0
55664,,5168100,CHEMBL1658748,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,4.0
55665,,5168107,CHEMBL1658749,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MBC,ug ml-1,UO_0000274,0.5
55666,,5168117,CHEMBL1658749,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MBC50,ug ml-1,UO_0000274,1.0
55667,,5168127,CHEMBL1658749,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MBC90,ug ml-1,UO_0000274,4.0
55668,,5168137,CHEMBL1658750,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
55669,,5168147,CHEMBL1658750,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.25
55670,,5168157,CHEMBL1658750,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,0.5
55671,,5168167,CHEMBL1658751,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,96.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,96.0
55672,,5168175,CHEMBL1658752,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,4.0
55673,,5168182,CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,0.5
55674,,5168192,CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC50,ug ml-1,UO_0000274,1.0
55675,,5168202,CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC90,ug ml-1,UO_0000274,4.0
55676,,5168212,CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.25
55677,,5168222,CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,0.25
55678,,5168232,CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,0.5
55679,,5168989,CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC,ug ml-1,UO_0000274,0.12
55680,,5168997,CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.12
55681,,5169005,CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.12
55682,,5169013,CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.12
55683,,5169021,CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,0.12
55684,,5169029,CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC,ug ml-1,UO_0000274,0.12
55685,,5169037,CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC,ug ml-1,UO_0000274,0.12
55686,,5169045,CHEMBL1667188,Antibacterial activity against Streptococcus pyogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.5
55687,Not Active,5169053,CHEMBL1667189,Antibacterial activity against Streptococcus anginosus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
55688,Not Active,5169061,CHEMBL1667190,Antibacterial activity against Streptococcus bovis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,Activity,,,
55689,Not Active,5169069,CHEMBL1667191,Antibacterial activity against Streptococcus constellatus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,Activity,,,
55690,Not Active,5169077,CHEMBL1667192,Antibacterial activity against Streptococcus intermedius assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,Activity,,,
55691,Not Active,5169085,CHEMBL1667193,Antibacterial activity against Streptococcus mitis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,Activity,,,
55692,Not Active,5169093,CHEMBL1667194,Antibacterial activity against Streptococcus oralis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,Activity,,,
55693,Not Active,5169101,CHEMBL1667195,Antibacterial activity against Streptococcus salivarius assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,Activity,,,
55694,Not Active,5169109,CHEMBL1667196,Antibacterial activity against Streptococcus sanguinis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,Activity,,,
55695,,5169118,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.5
55696,,5169126,CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1.0
55697,,5169133,CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC50,ug ml-1,UO_0000274,1.0
55698,,5169141,CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,ug ml-1,UO_0000274,1.0
55699,,5169149,CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC50,ug ml-1,UO_0000274,1.0
55700,,5169157,CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,ug ml-1,UO_0000274,1.0
55701,,5169165,CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC50,ug ml-1,UO_0000274,1.0
55702,,5169173,CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC50,ug ml-1,UO_0000274,1.0
55703,,5169181,CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC50,ug ml-1,UO_0000274,1.0
55704,,5169190,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.5
55705,,5169198,CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1.0
55706,,5169205,CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC90,ug ml-1,UO_0000274,4.0
55707,,5169213,CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,ug ml-1,UO_0000274,4.0
55708,,5169221,CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC90,ug ml-1,UO_0000274,4.0
55709,,5169229,CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC90,ug ml-1,UO_0000274,4.0
55710,,5169237,CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC90,ug ml-1,UO_0000274,4.0
55711,,5169245,CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC90,ug ml-1,UO_0000274,4.0
55712,,5169253,CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC90,ug ml-1,UO_0000274,4.0
55713,,5169260,CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.03
55714,,5169267,CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.015
55715,,5169274,CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.015
55716,,5169281,CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.015
55717,,5169288,CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,8.0
55718,,5169295,CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC50,ug ml-1,UO_0000274,0.5
55719,,5169302,CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC50,ug ml-1,UO_0000274,0.12
55720,,5169309,CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.06
55721,,5169316,CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,64.0
55722,,5169323,CHEMBL1658755,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,96.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,96.0
55723,,5169331,CHEMBL1658756,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,4.0
55724,,5169338,CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MBC,ug ml-1,UO_0000274,0.5
55725,,5169348,CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MBC50,ug ml-1,UO_0000274,1.0
55726,,5169358,CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MBC90,ug ml-1,UO_0000274,4.0
55727,,5169368,CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC,ug ml-1,UO_0000274,0.25
55728,,5169378,CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC50,ug ml-1,UO_0000274,0.25
55729,,5169388,CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC90,ug ml-1,UO_0000274,0.5
55730,,5169398,CHEMBL1658759,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,96.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,Activity,%,UO_0000187,96.0
55731,,5169406,CHEMBL1658760,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,Activity,%,UO_0000187,4.0
55732,,5169412,CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MBC,ug ml-1,UO_0000274,0.5
55733,,5169422,CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MBC50,ug ml-1,UO_0000274,1.0
55734,,5169432,CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MBC90,ug ml-1,UO_0000274,4.0
55735,,5169442,CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC,ug ml-1,UO_0000274,0.25
55736,,5169452,CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC50,ug ml-1,UO_0000274,0.25
55737,,5169462,CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC90,ug ml-1,UO_0000274,0.5
55738,,5169472,CHEMBL1658763,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,96.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,Activity,%,UO_0000187,96.0
55739,,5169481,CHEMBL1658921,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,Activity,%,UO_0000187,4.0
55740,,5169496,CHEMBL1658933,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
55741,,5169501,CHEMBL1658934,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,4.0
55742,,5169506,CHEMBL1658935,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,15.0
55743,,5169511,CHEMBL1658936,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,15.0
55744,,5169516,CHEMBL1658937,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,Activity,%,UO_0000187,15.0
55745,,5169521,CHEMBL1658938,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,Activity,%,UO_0000187,15.0
55746,,5169526,CHEMBL1658939,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,0.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,0.0
55747,,5169531,CHEMBL1658940,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
55748,,5169536,CHEMBL1658941,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,0.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,0.0
55749,,5169541,CHEMBL1658942,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,0.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,Activity,%,UO_0000187,0.0
55750,,5169546,CHEMBL1658943,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,0.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,Activity,%,UO_0000187,0.0
55751,,5169551,CHEMBL1658944,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,Activity,%,15.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,15.0
55752,,5169557,CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MBC,ug ml-1,UO_0000274,0.5
55753,,5169567,CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MBC50,ug ml-1,UO_0000274,1.0
55754,,5169577,CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,MBC90,ug ml-1,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MBC90,ug ml-1,UO_0000274,4.0
55755,,5170369,CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC90,ug ml-1,UO_0000274,8.0
55756,,5170376,CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC90,ug ml-1,UO_0000274,4.0
55757,,5170383,CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,2.0
55758,,5170390,CHEMBL1667197,Antibacterial activity against Acinetobacter baumannii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,37.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,37.7
55759,,5170397,CHEMBL1667198,Antibacterial activity against Acinetobacter calcoaceticus assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,66.7,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,Activity,%,UO_0000187,66.7
55760,,5170404,CHEMBL1667199,Antibacterial activity against Acinetobacter lwoffii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,86.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,Activity,%,UO_0000187,86.0
55761,,5170411,CHEMBL1667200,Antibacterial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,90.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,90.0
55762,,5170419,CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC,ug ml-1,UO_0000274,0.015
55763,,5170426,CHEMBL1667201,Antibacterial activity against Citrobacter koseri assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,99.0,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,Activity,%,UO_0000187,99.0
55764,,5170435,CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC50,ug ml-1,UO_0000274,0.03
55765,,5170443,CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC90,ug ml-1,UO_0000274,0.12
55766,,5170451,CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
55767,,5170458,CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.008
55768,,5170465,CHEMBL1667202,Antibacterial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,80.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,%,UO_0000187,80.0
55769,,5170472,CHEMBL1667203,Antibacterial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,92.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,92.0
55770,,5170479,CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC50,ug ml-1,UO_0000274,0.06
55771,,5170486,CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.03
55772,,5170493,CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,16.0
55773,,5170500,CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.25
55774,,5170507,CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.008
55775,,5170514,CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
55776,,5170521,CHEMBL1667204,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,0,=,Activity,ug ml-1,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,ug ml-1,UO_0000274,100.0
55777,,5170528,CHEMBL1667205,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,0,=,Activity,ug ml-1,27.3,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,ug ml-1,UO_0000274,27.3
55778,,5170535,CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
55779,,5170542,CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,8.0
55780,,5170549,CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.015
55781,,5170556,CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,16.0
55782,,5170564,CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.015
55783,,5170571,CHEMBL1667206,Antibacterial activity against Klebsiella oxytoca assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,90.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,90.0
55784,,5170580,CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC50,ug ml-1,UO_0000274,0.03
55785,,5170588,CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,0.5
55786,,5170595,CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.004
55787,,5170602,CHEMBL1667207,Antibacterial activity against Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,91.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,91.0
55788,,5170609,CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.06
55789,,5170616,CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,2.0
55790,,5170623,CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC,ug ml-1,UO_0000274,0.015
55791,,5170630,CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.008
55792,Not Active,5170638,CHEMBL1667208,Antibacterial activity against Legionella pneumophila assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1327196,,1,0,,Activity,,,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,Activity,,,
55793,,5170645,CHEMBL1667209,Antibacterial activity against Moraxella catarrhalis assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,Activity,%,UO_0000187,100.0
55794,,5170653,CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC50,ug ml-1,UO_0000274,0.03
55795,,5170660,CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.015
55796,,5170668,CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC90,ug ml-1,UO_0000274,0.03
55797,,5170675,CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.015
55798,,5170684,CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.015
55799,,5170691,CHEMBL1667210,Antibacterial activity against Morganella morganii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,76.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,Activity,%,UO_0000187,76.5
55800,,5170700,CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,0.06
55801,,5171750,CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,8.0
55802,,5171758,CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.004
55803,,5171764,CHEMBL1667338,Antibacterial activity against Neisseria meningitidis assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,%,UO_0000187,100.0
55804,,5171770,CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.008
55805,,5171776,CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.015
55806,,5171780,CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.015
55807,,5171787,CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.015
55808,,5171794,CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.06
55809,,5171801,CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
55810,,5171808,CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.03
55811,,5171815,CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.12
55812,,5171822,CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,4.0
55813,,5171829,CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,0.03
55814,,5171836,CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC50,ug ml-1,UO_0000274,0.03
55815,,5171843,CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,0.5
55816,,5171850,CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,16.0
55817,,5171857,CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.12
55818,,5171864,CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,1.0
55819,,5171871,CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,8.0
55820,,5171878,CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,8.0
55821,,5171885,CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,0.06
55822,,5171892,CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,1.0
55823,,5171899,CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,64.0
55824,,5171906,CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,0.5
55825,,5171913,CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,2.0
55826,,5171920,CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,32.0
55827,,5171927,CHEMBL1667339,Antibacterial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,76.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,76.0
55828,,5171934,CHEMBL1667340,Antibacterial activity against Proteus vulgaris assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,Activity,%,UO_0000187,100.0
55829,,5171941,CHEMBL1667341,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,96.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,96.2
55830,,5171948,CHEMBL1667342,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,1.0
55831,,5171955,CHEMBL1667343,Antibacterial activity against levofloxacin susceptible Serratia marcescens assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,100.0
55832,,5171962,CHEMBL1667344,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,100.0
55833,,5171969,CHEMBL1667346,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia assessed as assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,Activity,%,0.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,0.0
55834,,5172692,CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,>,1,1,>,MIC,ug.mL-1,0.094,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.094
55835,,5172723,CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,32.0
55836,,5172725,CHEMBL1654759,Antimicrobial activity against Desulfovibrio fairfieldensis by Etest method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,32.0
55837,,5172738,CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,MIC50,ug.mL-1,0.75,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.75
55838,,5172767,CHEMBL1654762,Antimicrobial activity against Desulfovibrio piger by Etest method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,MIC,ug.mL-1,0.095,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.095
55839,,5172776,CHEMBL1654761,Antimicrobial activity against Desulfovibrio desulfuricans MB by Etest method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
55840,,5173169,CHEMBL1667374,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321812,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,1.0
55841,,5173170,CHEMBL1667375,Antimicrobial activity against Pseudomonas aeruginosa isolate NH57388A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321812,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,2.0
55842,,5173179,CHEMBL1667380,"Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 125 mg/kg, ip BID administered 24 hrs post infection",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1321812,=,1,0,=,log10cfu,,3.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,3.5
55843,,5173180,CHEMBL1667381,"Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 63 mg/kg, ip BID administered 24 hrs post infection",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1321812,=,1,0,=,log10cfu,,2.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,2.7
55844,,5173181,CHEMBL1667382,"Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 32 mg/kg, ip BID administered 24 hrs post infection",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1321812,=,1,0,=,log10cfu,,0.65,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,0.65
55845,,5173188,CHEMBL1667383,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as lung bacterial load at 60 mg/kg, ip BID administered 24 hrs post infection (Rvb = 8.89 logCFU)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1321812,=,1,0,=,log10cfu,,4.93,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,4.93
55846,,5173189,CHEMBL1667384,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as lung bacterial load at 30 mg/kg, ip BID administered 24 hrs post infection (Rvb = 8.89 logCFU)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1321812,=,1,0,=,log10cfu,,5.73,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,5.73
55847,,5173190,CHEMBL1667385,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as lung bacterial load at 15 mg/kg, ip BID administered 24 hrs post infection (Rvb = 8.89 logCFU)",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,1321812,=,1,0,=,log10cfu,,7.83,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,log10cfu,,,7.83
55848,,5173802,CHEMBL1654760,Antimicrobial activity against Desulfovibrio desulfuricans Essex 6 by Etest method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
55849,,5176037,CHEMBL1666916,Antimicrobial activity against SCCmec type IV vancomycin-intermediate Staphylococcus aureus isolate 06b41 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
55850,,5176183,CHEMBL1666911,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b4k6307 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
55851,,5176184,CHEMBL1666920,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 15b52 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
55852,,5176186,CHEMBL1665469,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy32 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
55853,,5176187,CHEMBL1665531,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate sh06024 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
55854,,5176189,CHEMBL1666919,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
55855,,5176190,CHEMBL1666921,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
55856,,5176191,CHEMBL1666923,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
55857,,5176197,CHEMBL1665470,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy39 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55858,,5176198,CHEMBL1665530,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 5zjsau3 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55859,,5176199,CHEMBL1666908,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k2345 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55860,,5176200,CHEMBL1666909,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b2k3421 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55861,,5176202,CHEMBL1666912,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3529 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55862,,5176203,CHEMBL1666913,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3578 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55863,,5176205,CHEMBL1666914,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k1642 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
55864,,5176216,CHEMBL1666905,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 6zjsau7 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55865,,5176217,CHEMBL1666906,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate bd4768 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55866,,5176218,CHEMBL1666907,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate b2k4781 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55867,,5176219,CHEMBL1666910,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k5923 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55868,,5176221,CHEMBL1666917,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 13b16 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55869,,5176222,CHEMBL1666918,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 11b091 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55870,,5176224,CHEMBL1666922,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55871,,5176226,CHEMBL1666925,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,32.0
55872,,5176234,CHEMBL1665532,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06040 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,64.0
55873,,5176236,CHEMBL1665533,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06051 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,64.0
55874,,5176245,CHEMBL1666915,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k7974 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,64.0
55875,,5176249,CHEMBL1666924,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz07030 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,64.0
55876,,5177908,CHEMBL1659089,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
55877,,5177915,CHEMBL1659090,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 144 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
55878,,5177927,CHEMBL1659092,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 147 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,8.0
55879,,5177934,CHEMBL1659093,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 56 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
55880,,5177941,CHEMBL1659094,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 152 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
55881,,5179126,CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.012
55882,,5179135,CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,1.0
55883,,5179144,CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,1.0
55884,,5179153,CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC,ug ml-1,UO_0000274,0.1
55885,,5179160,CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC50,ug ml-1,UO_0000274,0.25
55886,,5179167,CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC90,ug ml-1,UO_0000274,0.5
55887,,5179195,CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55888,,5179206,CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC50,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug/L,UO_0000274,1.0
55889,,5179217,CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC90,ug.mL-1,0.002,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug/L,UO_0000274,2.0
55890,,5179228,CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.5
55891,,5179239,CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC50,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug/L,UO_0000274,1.0
55892,,5179250,CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC90,ug.mL-1,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug/L,UO_0000274,4.0
55893,,5179261,CHEMBL1660034,Antibacterial activity against Mycoplasma genitalium G37 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55894,,5179272,CHEMBL1660035,Antibacterial activity against Mycoplasma genitalium M30 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55895,,5179283,CHEMBL1660036,Antibacterial activity against Mycoplasma genitalium R32 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55896,,5179294,CHEMBL1660037,Antibacterial activity against Mycoplasma genitalium TW10-5G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55897,,5179305,CHEMBL1660038,Antibacterial activity against Mycoplasma genitalium TW10-6G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55898,,5179316,CHEMBL1660039,Antibacterial activity against Mycoplasma genitalium TW48-5G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55899,,5179327,CHEMBL1660040,Antibacterial activity against Mycoplasma genitalium UTMB-10G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,1.0
55900,,5179338,CHEMBL1660041,Antibacterial activity against Mycoplasma genitalium M2282 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55901,,5179349,CHEMBL1660042,Antibacterial activity against Mycoplasma genitalium M2300 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55902,,5179360,CHEMBL1660043,Antibacterial activity against Mycoplasma genitalium M2321 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55903,,5179371,CHEMBL1660044,Antibacterial activity against Mycoplasma genitalium M2341 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55904,,5179382,CHEMBL1660045,Antibacterial activity against Mycoplasma genitalium M6257 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55905,,5179393,CHEMBL1660046,Antibacterial activity against Mycoplasma genitalium M6280 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55906,,5179404,CHEMBL1660047,Antibacterial activity against Mycoplasma genitalium M6285 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55907,,5179415,CHEMBL1660048,Antibacterial activity against Mycoplasma genitalium M6286 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55908,,5179426,CHEMBL1660173,Antibacterial activity against Mycoplasma genitalium M6328 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55909,,5180480,CHEMBL1660174,Antibacterial activity against Mycoplasma genitalium M6090 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55910,,5180491,CHEMBL1660175,Antibacterial activity against Mycoplasma genitalium M6151 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55911,,5180502,CHEMBL1660176,Antibacterial activity against Mycoplasma genitalium M6282 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55912,,5180513,CHEMBL1660177,Antibacterial activity against Mycoplasma genitalium M6283 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55913,,5180524,CHEMBL1660178,Antibacterial activity against Mycoplasma genitalium M6284 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55914,,5180535,CHEMBL1660179,Antibacterial activity against Mycoplasma genitalium M6287 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,MIC,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.125
55915,,5181930,CHEMBL1660391,Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
55916,,5181931,CHEMBL1660390,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
55917,,5181932,CHEMBL1660389,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
55918,,5181933,CHEMBL1660389,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
55919,,5182026,CHEMBL1660388,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
55920,,5182034,CHEMBL1660387,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,4.0
55921,,5182042,CHEMBL1660386,Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
55922,,5182050,CHEMBL1660385,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
55923,,5182058,CHEMBL1660384,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
55924,,5182066,CHEMBL1660383,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
55925,,5182074,CHEMBL1660382,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
55926,,5182080,CHEMBL1660381,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.25
55927,,5182086,CHEMBL1660380,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.25
55928,,5182092,CHEMBL1660379,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.5
55929,,5182098,CHEMBL1660378,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
55930,,5182104,CHEMBL1660377,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
55931,,5182110,CHEMBL1660376,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.12
55932,,5182116,CHEMBL1660375,Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
55933,,5182122,CHEMBL1660374,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
55934,,5182128,CHEMBL1660373,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
55935,,5182134,CHEMBL1660372,Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
55936,,5182140,CHEMBL1660371,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
55937,,5182146,CHEMBL1660370,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
55938,,5182152,CHEMBL1660369,Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC,ug ml-1,UO_0000274,0.03
55939,,5182158,CHEMBL1660368,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC,ug ml-1,UO_0000274,0.03
55940,,5182164,CHEMBL1660367,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,MIC,ug ml-1,UO_0000274,0.25
55941,,5182173,CHEMBL1652892,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
55942,,5182183,CHEMBL1652894,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
55943,,5182193,CHEMBL1652896,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
55944,,5183335,CHEMBL1660388,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
55945,,5183343,CHEMBL1660387,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
55946,,5183351,CHEMBL1660386,Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
55947,,5183359,CHEMBL1660385,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
55948,,5183367,CHEMBL1660384,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
55949,,5183375,CHEMBL1660383,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
55950,,5183383,CHEMBL1660382,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
55951,,5183389,CHEMBL1660381,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
55952,,5183395,CHEMBL1660380,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
55953,,5183401,CHEMBL1660379,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,1.0
55954,,5183407,CHEMBL1660378,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.5
55955,,5183413,CHEMBL1660377,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.5
55956,,5183419,CHEMBL1660376,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,1.0
55957,,5183420,CHEMBL1660391,Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
55958,,5183421,CHEMBL1660390,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
55959,,5183426,CHEMBL1652900,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,94.1,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,94.1
55960,,5183431,CHEMBL1652901,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,100.0
55961,,5183435,CHEMBL1652902,Antimicrobial activity against Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,98.8,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,98.8
55962,,5183440,CHEMBL1652903,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,94.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,94.1
55963,,5183445,CHEMBL1652904,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
55964,,5183449,CHEMBL1652905,Antimicrobial activity against Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,98.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,98.8
55965,,5183454,CHEMBL1652906,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,94.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,94.1
55966,,5183459,CHEMBL1652907,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
55967,,5183463,CHEMBL1652908,Antimicrobial activity against Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,98.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,98.8
55968,,5183468,CHEMBL1652909,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,99.2
55969,,5183473,CHEMBL1652910,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,100.0
55970,,5183478,CHEMBL1652911,Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.9,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,99.9
55971,,5183483,CHEMBL1652912,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,95.9,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,95.9
55972,,5183488,CHEMBL1652913,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,98.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,98.6
55973,,5183493,CHEMBL1652914,Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,97.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,97.8
55974,,5183500,CHEMBL1652915,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,0.0
55975,,5183507,CHEMBL1652916,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,0.2
55976,,5183514,CHEMBL1653016,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,0.2
55977,,5183521,CHEMBL1653017,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,28.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,28.3
55978,,5183528,CHEMBL1653018,Antimicrobial activity against Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,12.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,12.2
55979,,5183535,CHEMBL1653019,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,0.0
55980,,5183542,CHEMBL1653020,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,0.0
55981,,5183549,CHEMBL1653021,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,0.0
55982,,5183556,CHEMBL1653022,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,64.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,64.4
55983,,5183563,CHEMBL1653023,Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,61.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,61.2
55984,,5183590,CHEMBL1653036,Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.1
55985,,5183870,CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323829,=,1,1,=,MIC,ug.mL-1,0.0313,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.0313
55986,,5183879,CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323829,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,4.0
55987,,5183888,CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323829,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
55988,,5183897,CHEMBL1664555,Antimicrobial activity against Acinetobacter baumannii assessed as susceptible isolate by broth dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1323829,=,1,0,=,Activity,%,38.6,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,38.6
55989,,5183906,CHEMBL1664553,Antimicrobial activity against Acinetobacter baumannii assessed as resistant isolate by broth dilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1323829,=,1,0,=,Activity,%,32.8,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,32.8
55990,,5184170,CHEMBL1653421,Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327134,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
55991,,5184171,CHEMBL1653421,Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327134,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,1.0
55992,,5184172,CHEMBL1653421,Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327134,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
55993,,5184173,CHEMBL1653422,Antibacterial activity against Streptococcus pneumoniae assessed as susceptible isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327134,=,1,0,=,Activity,%,99.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.4
55994,,5184174,CHEMBL1653423,Antibacterial activity against Streptococcus pneumoniae assessed as intermediate isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327134,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
55995,,5184175,CHEMBL1653424,Antibacterial activity against Streptococcus pneumoniae assessed as resistant isolates by CLSI M100-S17 method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1327134,=,1,0,=,Activity,%,0.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.6
55996,,5184651,CHEMBL1653038,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.5
55997,,5184660,CHEMBL1653040,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,97.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,97.7
55998,,5184669,CHEMBL1653042,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,99.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.3
55999,,5184674,CHEMBL1653035,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,Activity,%,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,Activity,%,UO_0000187,0.0
